Biomedical Translation Bridge initiative

The Biomedical Translation Bridge (BTB) is now part of the Medical Research Commercialisation initiative under the MRFF 10-year Investment Plan.

About the initiative

The Biomedical Translation Bridge (BTB) funds and nurtures early-stage health and medical research to reach proof-of-concept with the potential to attract further capital and support. It is now part of the Medical Research Commercialisation initiative under the MRFF 10-year plan. 

Why it is important

The BTB helps researchers transform their ideas into new treatments to help tomorrow’s patients.

Early-stage research is the first step towards future medical treatments. Taking a project from an idea to a final product is a long and expensive process. The BTB helps Australian medical researchers develop life-saving medicines, devices and treatments.

The BTB helps boost overall investment in biomedical research. This is because projects also attracted matched funding from other sources.


The BTB addresses key national gaps in Australia’s research sector and support three goals:

  • increased commercialisation focus and expertise in early stage research and decision-making across Australia
  • accelerated development, and improved success
  • helped to identify existing and new sources of capital investment to bolster awareness and interest in early research investment opportunities

Meeting our goals

After a competitive process, the Government chose MTPConnect to deliver the BTB. MTPConnect is a not-for-profit organisation formed to accelerate the growth of Australia’s medical technologies, biotechnologies and pharmaceuticals sector.

Who we work with

The BTB is part of the Australian Government’s Medical Research Future Fund (MRFF).

MTPConnect has partnered with the following organisations to deliver the BTB:

  • BioCurate, founded by the University of Melbourne and Monash University to boost development of new medicines
  • UniQuest, the University of Queensland’s specialist centre for commercialising intellectual property
  • Medical Device Partnering Program (MDPP), led by Flinders University to turn ideas for medical devices into realities

Apply for funding

See MTPConnect’s Biomedical Translation Bridge page for information about funding opportunities.


The Biomedical Translation Bridge now forms part of the Medical Research Commercialisation initiative.


For more information contact MTPConnect.

MTPConnect contact

MTPConnect is administering the BioMedTech Horizons, the Biomedical Translation Bridge, a Stream under Early Stage Translation and Commercialisation Support, and the REDI initiative. Contact MTPConnect for information about these activities (funded by the MRFF).
Date last updated:

Help us improve

If you would like a response please use the enquiries form instead.